Pegfilgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) designed to stimulate the production of white blood cells (neutrophils). It is commonly used to reduce the incidence of infection in patients undergoing chemotherapy, which often leads to neutropenia—a dangerous drop in white blood cells.